Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY: ZBH )

110.62 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 373
Open 110.62
Bid (Size) 109.61 (2)
Ask (Size) 143.80 (1)
Prev. Close 110.62
Today's Range 110.62 - 110.62
52wk Range 100.67 - 133.90
Shares Outstanding 208,569,285
Dividend Yield 0.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details
Zimmer Biomet agrees to acquire Paragon 28 for $1.1 billion, with a non-tradeable CVR up to $1 per share. Deal expected to close in first half of 2025. 
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock
Via Benzinga

Performance

YTD
+5.90%
+5.90%
1 Month
+4.72%
+4.72%
3 Month
+3.46%
+3.46%
6 Month
-0.45%
-0.45%
1 Year
-11.93%
-11.93%

More News

Read More
Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
Via MarketBeat
Exposures Product Safety
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead
Via MarketBeat
What 21 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Via Benzinga
(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
Via Benzinga
13 Healthcare Sector Stocks With Healthy Valuation
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
Via Benzinga
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Analyst Expectations For Zimmer Biomet Holdings's Future
Via Benzinga
Looking Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
Navigating 14 Analyst Ratings For Zimmer Biomet Holdings
Via Benzinga
Assessing Zimmer Biomet Holdings: Insights From 8 Financial Analysts
Via Benzinga
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
Via Benzinga
Exposures Product Safety
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Via MarketBeat
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Zimmer Biomet Hammered, Sales Expected To Take A Surprise 1% Hit
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Via MarketBeat
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Medical Technology Stock Benefits from Rising Acute Care Demand
Via MarketBeat
Topics Supply Chain
Exposures Supply Chain
Why Intuitive Surgical Stock is Dominating the Medical Sector
Via MarketBeat
3 Healthcare Stocks to Buy at a 52-Week Low in July
Via InvestorPlace
ZimVie Stock Launches 15% Into Breakout Territory On Rumored Takeover
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.